Antiemetics Drugs Market Size, Share & Trends Report

Antiemetics Drugs Market Size, Share & Trends Analysis Report By Drug Type (Serotonin-receptor Antagonists, Dopamine Receptor Antagonists), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-165-9
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2018 - 2022
Industry: Healthcare

Market Segmentation

Antiemetics Drugs Drug Type Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Serotonin-Receptor Antagonists
- Anticholinergics
- Dopamine Receptor Antagonists
- Neurokinin Receptor Antagonists
- Others (Antihistamines, Cannabinoids)
Antiemetics Drugs Application Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Chemotherapy
- Gastroenteritis
- Post Operative Surgery
- Others (Vertigo, Motion Sickness)
Antiemetics Drugs End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital & Clinics
- Retail Pharmacy
- Others
Antiemetics Drugs Regional Outlook (Revenue, USD Million; 2018 - 2030)
- North America
  - North America Drug Type Outlook
    - Serotonin-Receptor Antagonists
    - Anticholinergics
    - Dopamine Receptor Antagonists
    - Neurokinin Receptor Antagonists
    - Others (Antihistamines, Cannabinoids)
  - North America Application Outlook
    - Chemotherapy
    - Gastroenteritis
    - Post Operative Surgery
    - Others (Vertigo, Motion Sickness)
  - North America End-use Outlook
    - Hospital & Clinics
    - Retail Pharmacy
    - Others
  - U.S.
    - U.S. Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - U.S. Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - U.S. End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Canada
    - Canada Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Canada Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Canada End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
- Europe
  - Europe Drug Type Outlook
    - Serotonin-Receptor Antagonists
    - Anticholinergics
    - Dopamine Receptor Antagonists
    - Neurokinin Receptor Antagonists
    - Others (Antihistamines, Cannabinoids)
  - Europe Application Outlook
    - Chemotherapy
    - Gastroenteritis
    - Post Operative Surgery
    - Others (Vertigo, Motion Sickness)
  - Europe End-use Outlook
    - Hospital & Clinics
    - Retail Pharmacy
    - Others
  - UK
    - UK Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - UK Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - UK End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Germany
    - Germany Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Germany Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Germany End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - France
    - France Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - France Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - France End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Italy
    - Italy Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Italy Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Italy End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Spain
    - Spain Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Spain Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Spain End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Denmark
    - Denmark Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Denmark Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Denmark End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Norway
    - Norway Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Norway Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Norway End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Sweden
    - Sweden Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Sweden Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
    - Others (Vertigo, Motion Sickness)
      - Sweden End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
- Asia Pacific
  - Asia Pacific Drug Type Outlook
    - Serotonin-Receptor Antagonists
    - Anticholinergics
    - Dopamine Receptor Antagonists
    - Neurokinin Receptor Antagonists
    - Others (Antihistamines, Cannabinoids)
  - Asia Pacific Application Outlook
    - Chemotherapy
    - Gastroenteritis
    - Post Operative Surgery
    - Others (Vertigo, Motion Sickness)
  - Asia Pacific End-use Outlook
    - Hospital & Clinics
    - Retail Pharmacy
    - Others
  - Japan
    - Japan Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Japan Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Japan End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - China
    - China Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - China Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - China End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - India
    - India Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - India Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - India End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - South Korea
    - South Korea Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - South Korea Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - South Korea End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Australia
    - Australia Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Australia Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Australia End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Thailand
    - Thailand Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Thailand Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Thailand End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
- Latin America
  - Latin America Drug Type Outlook
    - Serotonin-Receptor Antagonists
    - Anticholinergics
    - Dopamine Receptor Antagonists
    - Neurokinin Receptor Antagonists
    - Others (Antihistamines, Cannabinoids)
  - Latin America Application Outlook
    - Chemotherapy
    - Gastroenteritis
    - Post Operative Surgery
    - Others (Vertigo, Motion Sickness)
  - Latin America End-use Outlook
    - Hospital & Clinics
    - Retail Pharmacy
    - Others
  - Brazil
    - Brazil Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Brazil Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Brazil End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Argentina
    - Argentina Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Argentina Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Argentina End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Mexico
    - Mexico Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Mexico Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Mexico End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
- Middle East and Africa
  - Middle East and Africa Drug Type Outlook
    - Serotonin-Receptor Antagonists
    - Anticholinergics
    - Dopamine Receptor Antagonists
    - Neurokinin Receptor Antagonists
    - Others (Antihistamines, Cannabinoids)
  - Middle East and Africa Application Outlook
    - Chemotherapy
    - Gastroenteritis
    - Post Operative Surgery
    - Others (Vertigo, Motion Sickness)
  - Middle East and Africa End-use Outlook
    - Hospital & Clinics
    - Retail Pharmacy
    - Others
  - South Africa
    - South Africa Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - South Africa Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - South Africa End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Saudi Arabia
    - Saudi Arabia Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Saudi Arabia Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Saudi Arabia End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - UAE
    - UAE Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - UAE Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - UAE End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others
  - Kuwait
    - Kuwait Drug Type Outlook
      - Serotonin-Receptor Antagonists
      - Anticholinergics
      - Dopamine Receptor Antagonists
      - Neurokinin Receptor Antagonists
      - Others (Antihistamines, Cannabinoids)
    - Kuwait Application Outlook
      - Chemotherapy
      - Gastroenteritis
      - Post Operative Surgery
      - Others (Vertigo, Motion Sickness)
    - Kuwait End-use Outlook
      - Hospital & Clinics
      - Retail Pharmacy
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.